Ellipsys Medical, Inc.
About Ellipsys Medical, Inc.
Ellipsys Medical, Inc. is dedicated to advancing vascular access technologies that improve patient outcomes in end-stage renal disease. The company partners with clinicians and health systems to deliver solutions that enhance care quality, streamline workflows, and support long-term access durability. The Ellipsys System enables physicians to create a percutaneous AV fistula using a single catheter under ultrasound guidance. The procedure can be performed in multiple care settings and is designed to support long-term access durability.
- 🔗 Ellipsys Medical has filed a notice of an exempt offering of securities to raise $10,850,000.00 in New Funding. - intelligence360
- 🔗 Ellipsys Medical Company Overview, Contact Details & Competitors | LeadIQ
- 🔗 CVS, Salesforce back Ellipsis Health's $45M series A raise
- 🔗 Avenu Medical pulls in $6m for Ellipsys AV fistula device - MassDevice
- 🔗 Ellipsys Vascular Access System to Return to U.S. Market in 2026
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Company filed for $8.57M private placement in Other Health Care sector.
- Ellipsys System creates percutaneous AV fistulas via single ultrasound-guided catheter.
- Product targets end-stage renal disease vascular access with multi-setting use.
- Email contact listed as [email protected].
Ask StreetZero about Ellipsys Medical, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account